Crossref
Optimization of an Orally Bioavailable Plasma Kallikrein Inhibitor
Synfacts · 01.05.2026 · 22 (05) · 475
DOI: 10.1055/a-2829-1481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synfacts, erschienen am 01.05.2026. Verfasst von Antonia F. Stepan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stepan, A. F., & Puleo, T. R. (2026). Optimization of an Orally Bioavailable Plasma Kallikrein Inhibitor. Synfacts, 22(05), 475. https://doi.org/10.1055/a-2829-1481
Vancouver
Stepan AF, Puleo TR. Optimization of an Orally Bioavailable Plasma Kallikrein Inhibitor. Synfacts. 2026;22(05):475. doi:10.1055/a-2829-1481
BibTeX
@article{Stepan2026,
author = {Stepan, Antonia F. and Puleo, Thomas R.},
title = {Optimization of an Orally Bioavailable Plasma Kallikrein Inhibitor},
journal = {Synfacts},
year = {2026},
volume = {22},
number = {05},
pages = {475},
doi = {10.1055/a-2829-1481}
}
EUVIMED